Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors

Clinical trial NCT00028535 · COMPLETED

Trial details

NCT number: NCT00028535
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Male Breast Cancer Recurrent Breast Cancer Recurrent Endometrial Carcinoma Recurrent Gastric Cancer Recurrent Non-small Cell Lung Cancer Recurrent Ovarian Epithelial Cancer Recurrent Small Cell Lung Cancer

Start date: 2001-11-01
Primary completion: 2009-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.